Kelcee Everette, PhD

Associate

Kelcee Everette is an Associate with the TechAtlas team at RA Capital Management. Kelcee primary responsibilities are to closely with members of the investment team and portfolio companies to deeply understand competitive landscapes, evaluate investment opportunities in a variety of therapeutic areas across all stages from discovery and new company creation through commercialization, and advise portfolio companies on program and pipeline strategy. Prior to joining RA Capital, Kelcee worked as a Postdoctoral Associate at the Broad Institute of MIT and Harvard and as an Associate at Civilization Ventures. She also served as a Fellow at F‑Prime Capital. Kelcee holds a PhD in Biological and Biomedical Sciences from Harvard University where she led research in the therapeutic applications of precision genome editing technologies. Kelcee additionally earned a certificate in the Therapeutics Graduate Program and holds a BA in Biomedical Engineering from Harvard University.